Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ark Genomic Revolution Multi-Sector ETF (ARKG)

Ark Genomic Revolution Multi-Sector ETF (ARKG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 423,464,000
  • Market Capitalization, $K 423,464
  • Shares Outstanding, K 13,405
  • 60-Month Beta 1.93
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.27 (0.86%)
  • Most Recent Dividend 0.270 on 12/27/18
  • Management Fee 0.75%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.01 +17.21%
on 10/25/19
33.28 -1.36%
on 11/19/19
+4.41 (+15.52%)
since 10/18/19
3-Month
27.62 +18.86%
on 10/03/19
33.28 -1.36%
on 11/19/19
+0.01 (+0.03%)
since 08/19/19
52-Week
21.98 +49.36%
on 12/24/18
35.54 -7.63%
on 07/31/19
+4.89 (+17.50%)
since 11/19/18

Most Recent Stories

More News
Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks

Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.

PTH : 86.69 (+2.58%)
PBE : 52.92 (+1.38%)
XBI : 87.21 (+2.56%)
CNCR : 21.96 (+2.49%)
DXCM : 217.58 (+1.78%)
CLVS : 7.79 (+10.34%)
BIIB : 285.43 (+0.99%)
PTI : 1.09 (+0.93%)
AQST : 5.44 (+0.55%)
FTSV : 10.97 (+7.18%)
ARKG : 32.83 (+3.98%)
S&P 500 at Record High: 6 ETF Winners of Last Week

The S&P 500 hit record highs last week, with the index rising for the fourth consecutive week, marking its longest winning streak since March.

PRNT : 21.36 (-0.19%)
XSD : 98.92 (-0.05%)
BBC : 28.95 (+4.42%)
VETS : 31.25 (+3.23%)
LEND : 19.63 (-5.37%)
ARKG : 32.83 (+3.98%)
Navigating The Healthcare Industry: Science Fiction Turns to Reality

Kevin Cook joins us to help walk us through the maze that is the healthcare industry. We touch on everything from the hottest trends all the way down to how to pick a winning stock!

IBB : 113.45 (+1.99%)
XBI : 87.21 (+2.56%)
SBIO : 37.07 (+2.80%)
EW : 243.56 (+0.49%)
GWPH : 103.56 (+1.06%)
FOMX : 3.40 (-2.30%)
CRSP : 68.46 (+16.97%)
ARKG : 32.83 (+3.98%)
Tap Revenue Growth With These ETFs & Dump Earnings Recession

These sector ETFs could be played to highlight revenue growth in the third quarter.

EBAY : 35.06 (-0.11%)
PMR : 41.32 (-1.27%)
XLP : 61.57 (-0.13%)
XLF : 29.87 (+0.20%)
XLY : 120.45 (-1.10%)
XLU : 62.82 (-0.25%)
JWN : 35.50 (-6.26%)
TGT : 110.85 (-0.99%)
WMT : 119.89 (-0.30%)
KSS : 47.02 (-19.49%)
ARKG : 32.83 (+3.98%)
Tap Revenue Growth With These ETFs & Dump Earnings Recession

These sector ETFs could be played to highlight revenue growth in the third quarter.

EBAY : 35.06 (-0.11%)
PMR : 41.32 (-1.27%)
XLP : 61.57 (-0.13%)
XLF : 29.87 (+0.20%)
XLY : 120.45 (-1.10%)
XLU : 62.82 (-0.25%)
JWN : 35.50 (-6.26%)
TGT : 110.85 (-0.99%)
WMT : 119.89 (-0.30%)
KSS : 47.02 (-19.49%)
ARKG : 32.83 (+3.98%)
ETFs Poised to Benefit from Gene Editing Revolution

Rising investments and growing technological advancement are favoring the genomic editing space. We take a look at a few ETFs that can cash in on this trend.

AGN : 185.22 (+0.39%)
PBE : 52.92 (+1.38%)
ONCE : 111.33 (+0.16%)
EDIT : 24.96 (+7.82%)
ARKG : 32.83 (+3.98%)
GNOM : 14.47 (+3.67%)
IDNA : 27.64 (+2.21%)
ETFs to Gain From the Booming Genomics Market

Rising investments, surging demand for personalized medicines and shrinking sequencing costs are a slew of factors favouring the genomics space. We look at a few ETFs that can cash in on this trend.

PBE : 52.92 (+1.38%)
ILMN : 311.01 (+1.42%)
IDNA : 27.64 (+2.21%)
GNOM : 14.47 (+3.67%)
ARKG : 32.83 (+3.98%)
Top-Performing Biotech ETFs YTD

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.

RHHBY : 38.3000 (+0.71%)
BMY : 56.48 (-2.03%)
XBI : 87.21 (+2.56%)
BTEC : 35.13 (+2.67%)
BBH : 135.52 (+1.40%)
SBIO : 37.07 (+2.80%)
ILMN : 311.01 (+1.42%)
CELG : 108.13 (-1.09%)
GILD : 65.00 (+1.10%)
GLPG : 184.35 (-2.19%)
AMGN : 224.50 (+1.74%)
EC : 17.96 (-0.39%)
ARKG : 32.83 (+3.98%)
5 U.S. ETFs Seeing Fireworks Ahead of July Fourth

These ETFs focus exclusively on U.S. equities and deserve the attention of investors seeking a domestic tilt to their portfolio ahead of the Jul 4 holiday.

IPO : 30.35 (unch)
PBW : 30.66 (-0.36%)
PTF : 75.83 (+1.38%)
DWAQ : 112.90 (+1.14%)
ARKG : 32.83 (+3.98%)
5 Sector ETFs That Beat the Market in the First Half

With just a trading session left to end the first half, the Dow Jones is up about 13.7% while the S&P 500 and Nasdaq have gained 16.7% and 20.1%, respectively.

PPA : 69.85 (-0.21%)
PTF : 75.83 (+1.38%)
TAN : 27.78 (+0.83%)
PFI : 38.16 (+0.33%)
ARKG : 32.83 (+3.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade ARKG with:

Fund Summary

The ARK Genomic Revolution Multi-Sector ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology,...

See More

Key Turning Points

2nd Resistance Point 33.99
1st Resistance Point 33.41
Last Price 32.83
1st Support Level 32.13
2nd Support Level 31.42

See More

52-Week High 35.54
Last Price 32.83
Fibonacci 61.8% 30.36
Fibonacci 50% 28.76
Fibonacci 38.2% 27.16
52-Week Low 21.98

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar